Table 1 Symptoms and endoscopic appearances in controls and inflammatory bowel disease
From: Paneth cell metaplasia in newly diagnosed inflammatory bowel disease in children
Control | UC | CD | ||
|---|---|---|---|---|
N | 14 | 13 | 15 | |
Sex (M/F) | 10/4 | 6/7 | 5/10 | |
Age range (median) | 6-16 (12.5) | 6-15 (14) | 7-16 (13) | |
Symptoms: n (%) | Diarrhoea | 9 (64) | 8 (62) | 8 (53) |
Abdominal pain | 9 (64) | 4 (31) | 7 (47) | |
Rectal bleeding | 6 (43) | 10 (77) | 6 (40) | |
Weight loss | 4 (29) | 6 (46) | 2 (13) | |
Treatment prior to diagnosis: n (%) | Antiinflammatories | 2 (14) | 7 (54)* | 7 (47) |
Infliximab | 0 | 4 (31)* | 0 | |
Immunosuppressants | 0 | 6 (46)† | 1 (7) | |
Endoscopic appearance: n (%) | Abnormal | 1 (7)‡ | 13 (100)§ | 15 (100)§ |
Terminal ileitis | 1 (7)‡ | 0 | 5 (33) | |
Extensive colitis | 0 | 7 (54)† | 3 (20) | |
Discontinuous colitis | 1 (7)‡ | 1 (8) | 7 (47)* | |
Left-sided colitis only | 0 | 5 (38)* | 0 | |
Recto-sigmoid colitis only | 0 | 2 (15) | 0 | |